University of California researchers to hold meeting in San Diego to discuss hematologic malignancies as part of the University of California Hematologic Malignancies Consortium, a first-of-its-kind research group that brings together the five UC health campuses conducting clinical studies for cancer patients. The consortium currently has four additional clinical trials planned for 2017.
Loneliness is linked to poor physical and mental health, and is an even more accurate predictor of early death than obesity. To better understand who is at risk, researchers at University of California San Diego School of Medicine conducted the first genome-wide association study for loneliness — as a life-long trait, not a temporary state. They discovered that risk for feeling lonely is partially due to genetics, but environment plays a bigger role.
California Governor Edmund “Jerry” Brown signed into law today new state restrictions on the emissions of so-called short-lived climate pollutants such as methane, hydrofluorocarbons (HFCs) used in refrigeration, and soot and other forms of black carbon. The new law was inspired by decades of research by Scripps Institution of Oceanography at UC San Diego Climate and Atmospheric Scientist Veerabhadran Ramanathan.
CSE Prof. Tajana Rosing is the inaugural holder of an academic chair endowed in 2012 by John J. and Susan M. Fratamico to promote scholarship in fields including engineering and the life sciences.
If you’ve lived through your own or your kids’ adolescence, you know it’s an extraordinary time. Yet researchers know comparatively little about the teenage brain. The Adolescent Brain Cognitive Development (ABCD) study – by the National Institutes of Health, with leadership from the University of California San Diego – aims to change that. The largest long-term study of brain development and child health in the United States is now underway.
Researchers at University of California San Diego School of Medicine and Moores Cancer Center have identified a strategy to maximize the effectiveness of anti-cancer immune therapy. The researchers identified a molecular switch that controls immune suppression, opening the possibility to further improving and refining emerging immunotherapies that boost the body’s own abilities to fight diseases ranging from cancer to Alzheimer’s and Crohn’s disease.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
